Health Care & Life Sciences » Pharmaceuticals | Sawai Pharmaceutical Co. Ltd.

Sawai Pharmaceutical Co. Ltd.

Sawai Pharmaceutical Co. Ltd.
Stock Exchange Other OTC
EPS
$3.98
Market Cap
$2.47 B
Shares Outstanding
44.08 M
Public Float
-
Sawai Pharmaceutical Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY442.32
Market Cap
JPY267.48 B
Shares Outstanding
44.08 M
Public Float
36.82 M

Profile

Address
5-2-30 Miyahara
Osaka Osaka 532
Japan
Employees -
Website http://www.sawai.co.jp
Updated 07/08/2019
Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan.

Financials

View All

Hiroyuki Sawai
Chairman
Mitsuo Sawai
President & Representative Director